Choc cardiogénique - Docteur Synapse

Cardiogenic shock - Docteur Synapse
References :
1. Cotter G., Moshkovitz Y., Milovanov O., Salah A., Blatt A., Krakover R., Vered Z., Kaluski E. Acute heart failure: A novel approach to its pathogenesis and treatment. Eur J Heart Fail 2002 ; 4 : 227-234.

2. Hollenberg S.M., Kavinsky C.J., Parrillo J.E. Cardiogenic shock. Ann Intern Med 1999 ; 131 : 47-59.

3. Bybee K.A., Kara T., Prasad A., Lerman A., Barsness G.W., Wright R.S., Rihal C.S. Systematic review: Transient left ventricular apical ballooning: A syndrome that mimics st-segment elevation myocardial infarction. Ann Intern Med 2004 ; 141 : 858-865.

4. Babaev A., Frederick P.D., Pasta D.J., Every N., Sichrovsky T., Hochman J.S.. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 2005 ; 294 : 448-454.

5. Hochman J.S. Cardiogenic shock complicating acute myocardial infarction: Expanding the paradigm. Circulation 2003 ; 107 : 2998-3002.

6. Richards A.M., Nicholls M.G., Espiner E.A., Lainchbury J.G., Troughton R.W., Elliott J., Frampton C., Turner J., Crozier I.G., Yandle T.G. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 2003 ; 107 : 2786-2792.

7. De Backer D., Biston P., Devriendt J., Madl C., Chochrad D., Aldecoa C., Brasseur A., Defrance P., Gottignies P., Vincent J.L. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010 ; 362 : 779-789.

8. Beurtheret S., Mordant P., Paoletti X., Marijon E., Celermajer D.S., Leger P., Pavie A., Combes A., Leprince P. Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: A pilot study (the cardiac-rescue program). Eur Heart J 2012.